Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

281.62
Delayed Data
As of Sep 13
 -2.56 / -0.90%
Today’s Change
271.57
Today|||52-Week Range
442.00
-24.60%
Year-to-Date

Today’s Trading

Previous close284.18
Today’s open283.84
Day’s range279.47 - 287.00
Volume617,113
Average volume (3 months)800,636
Market cap$30.4B
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+100.98%
Earnings growth (this year)+2.58%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+14.28%
P/E ratio15.6
Price/Sales6.39
Price/Book3.50

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-0.86-0.79%
INCYIncyte Corp+0.36+0.47%
VRTXVertex Pharmaceutica...+2.49+1.44%
SGENSeattle Genetics Inc-0.25-0.35%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)$6.31
Annual revenue (last year)$6.7B
Annual profit (last year)$2.4B
Net profit margin36.42%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-President, Chief Executive Officer &
Director
Leonard S. Schleifer
Co-President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts